1. Home
  2. Live Updates
  3. Brii Biosciences Announces Topline Interim Results of Phase

Brii Biosciences Announces Topline Interim Results of Phase

Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B

Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Shanghai , China , Beijing , David Margolis , Brii Bio , Prnewswire Brii Biosciences Limited Bio , Brii Biosciences , Brii Biosciences Limited Bio , Biosciences Limited , Chief Medical Officer , Vir Biotechnology , Combination Study , Francisco Bay Area ,